Eric K. Rowinsky
2014
In 2014, Eric K. Rowinsky earned a total compensation of $1.7M as Former Executive Vice President, Chief Medical Officer and Head of Research and Development at Stemline Therapeutics, a 42% decrease compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $40,000 |
| Option Awards | $709,153 |
| Salary | $400,000 |
| Stock Awards | $350,349 |
| Total | $1,699,502 |
Rowinsky received $709.2K in option awards, accounting for 42% of the total pay in 2014.
Rowinsky also received $200K in bonus, $40K in non-equity incentive plan, $400K in salary and $350.3K in stock awards.
Rankings
In 2014, Eric K. Rowinsky's compensation ranked 5,223rd out of 13,032 executives tracked by ExecPay. In other words, Rowinsky earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,223 out of 13,032 | 60th |
Division Manufacturing | 1,867 out of 4,966 | 62nd |
Major group Chemicals And Allied Products | 627 out of 1,686 | 63rd |
Industry group Drugs | 479 out of 1,365 | 65th |
Industry Pharmaceutical Preparations | 379 out of 1,043 | 64th |
Source: SEC filing on April 8, 2016.
Rowinsky's colleagues
We found three more compensation records of executives who worked with Eric K. Rowinsky at Stemline Therapeutics in 2014.